Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2

被引：2
|
作者：
Yalcin, Nadir [1 ,2 ]
Demirkan, Kutay [1 ]
机构：
[1] Hacettepe Univ, Dept Clin Pharm, Fac Pharm, TR-06100 Ankara, Turkey
[2] Erasmus MC, Dept Clin Pharm, Rotterdam, Netherlands
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2023年 / 108卷 / 10期
关键词：
pharmacology; infectious disease medicine; global health;
D O I：
10.1136/archdischild-2022-324168
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic
    Barcelo-Vidal, J.
    Echeverria-Esnal, D.
    Carballo, N.
    De Antonio-Cusco, M.
    Fernandez-Sala, X.
    Navarrete-Rouco, M. E.
    Colominas-Gonzalez, E.
    Luque, S.
    Fuster-Esteva, M.
    Domingo, L.
    Sala, M.
    Duran, X.
    Grau, S.
    Ferrandez, O.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2
    Bahap, Melda
    Kara, Emre
    Sain Guven, Gulay
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (01)
  • [23] A CASE OF CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTIONS OF PAXLOVID (NIRMATRELVIR/RITONAVIR) WITH CONCURRENT MEDICATIONS IN THE MANAGEMENT OF COVID-19
    Weill, Sydney
    Reddy, Anisha
    Bugos, Eva
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S370 - S370
  • [24] Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions
    Elens, Laure
    Langman, Loralie J.
    Hesselink, Dennis A.
    Bergan, Stein
    Moes, Dirk Jan A. R.
    Molinaro, Mariadelfina
    Venkataramanan, Raman
    Lemaitre, Florian
    THERAPEUTIC DRUG MONITORING, 2020, 42 (03) : 360 - 368
  • [25] Safety pro file of nirmatrelvir-ritonavir: Evidence of adverse events due to drug-drug interactions
    Gonzalez-Gomez, Alvaro
    Caro-Teller, Jose Manuel
    Gonzalez-Barrios, Ivan
    Castro-Frontinan, Almudena
    Rodriguez-Quesada, Pedro Pablo
    Ferrari-Piquero, Jose Miguel
    FARMACIA HOSPITALARIA, 2024, 48 (02) : 70 - 74
  • [26] Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir
    Gonzalez-Garcia, Ruben
    Roma, Joan-Ramon
    Rodriguez-Garcia, Maria
    Arranz, Natalia
    Ambrosioni, Juan
    Bodro, Marta
    Castel, Maria-Angeles
    Cofan, Federic
    Crespo, Gonzalo
    Diekmann, Fritz
    Farrero, Marta
    Forner, Alejandro
    LLigona, Ana
    Marcos, Maria Angeles
    Moreno, Asuncion
    Ruiz, Pablo
    Soy, Dolors
    Brunet, Merce
    Miro, Jose M.
    Tuset, Montse
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (05) : 655e1 - 655e4
  • [27] Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)
    Lemaitre, Florian
    Gregoire, Matthieu
    Monchaud, Caroline
    Bouchet, Stephane
    Saint-Salvi, Beatrice
    Polard, Elisabeth
    Benaboud, Sihem
    Chouchana, Laurent
    Cracowski, Jean-Luc
    Drici, Milou-Daniel
    Garraffo, Rodolphe
    Guilhaumou, Romain
    Jonville-Bera, Annie-Pierre
    Molimard, Mathieu
    Muret, Patric
    Peytavin, Gilles
    Richard, Vincent
    Solas, Caroline
    THERAPIE, 2022, 77 (05): : 509 - 521
  • [28] Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)
    Lemaitre, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 7 - 7
  • [29] Nirmatrelvir/ritonavir treatment of patients with COVID-19 taking tacrolimus: case series describing the results of drug-drug interactions
    Shen, Dan
    Gong, Yinhua
    Qian, Yulan
    Zhu, Jianguo
    Gao, Jie
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (05)
  • [30] Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
    Alfredo Jose Pardo-Cabello
    Victoria Manzano-Gamero
    Susana Belda-Rustarazo
    Pilar Giner-Escobar
    Internal and Emergency Medicine, 2021, 16 : 797 - 798
12345